Understanding and Controlling Infectious Diseases: an agenda for the 21st century

The 120th anniversary of the foundation of the Institut Pasteur will take place in 2008. One of the events to highlight this celebration will be the 7th Louis Pasteur Conference on Infectious Diseases. This two-day conference will gather the world’s best experts in the fields of epidemiology, public health, microbiology and immunology. The major goals of the Conference will be to present cutting-edge concepts and methodologies and discuss how they might increase our ability to monitor emerging infectious diseases, model and control epidemics, understand pathogenesis at the molecular and cellular levels, discover new drugs, dissect the host immunity, and generate new vaccines. The Conference will consist of four sessions, each opening with a historical perspective presenting past achievements and how basic research has been able to eliminate critical ‘roadblocks’, and closing with a talk stressing the remaining challenges in controlling infectious diseases.

http://www.pasteur.fr/infosci/conf/sb/clp7/program.html

Françoise Barré-Sinoussi, Institut Pasteur, Paris, France
Philippe Bousso, Institut Pasteur, Paris, France
John Clemens, International Vaccine Institute, Seoul, Korea
Pascale Cossart, Institut Pasteur, Paris, France
Patrice Courvalin, Institut Pasteur, Paris, France
Julian Davies, University of British Columbia, Vancouver, Canada
Ogobara Doumbo, University of Bamako, Mali
Antoine Gessain, Institut Pasteur, Paris, France
Laurent Gutmann, Hôpital Européen Georges-Pompidou, Paris, France
Richard Hatchett, NIH, USA
Karla Kirkegaard, Stanford University, USA
Claude Leclerc, Institut Pasteur, Paris, France
Elena Levashina, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France
Marc Lipsitch, Harvard school of Public Health, USA
Robert May, Oxford University, UK
Didier Mazel, Institut Pasteur, Paris, France
Gustav Nossal, Melbourne University, Australia
Victor Nussenzweig, NYU Medical Center, USA
Malik Peiris, Hong Kong University Pasteur Research Center, Hong Kong SAR
Rino Rappuoli, Novartis Vaccines, Siena, Italy
David Roos, University of Pennsylvania, Philadelphia, USA
Philippe Sansonetti, Institut Pasteur, Paris, France
David Sibley, Washington University School of Medicine, USA
Ralph Steinman, The Rockefeller University, New York, USA
Peter Strebel, Centers for Disease Control and Prevention, Atlanta, USA
Robin Weiss, University College of London, UK
Arturo Zychlinsky, MPI für Infektionsbiologie, Berlin, Germany